Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 30,058
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12559504 | Benzotriazole derivative | 🖼🧊📄§ | 2026-02-24 | 2040-05-29 | 0 | 31 |
| 12558360 | Compound useful for the treatment of degenerative and inflammatory diseases | 🖼🧊📄§ | 2026-02-24 | 2044-06-13 | 0 | 31 |
| 12559461 | Antibiotic adjuvant compounds | 🖼🧊📄§ | 2026-02-24 | 2041-04-19 | 0 | 31 |
| 12559563 | Müllerian inhibiting substance type 2 receptor (MISIIR)-specific CAR T cells for the treatment of ovarian cancer and other gynecologic malignancies | 🖼🧊📄§ | 2026-02-24 | 2040-04-14 | 0 | 31 |
| 12558371 | Chondroitin sulfate polysaccharide, and semi-synthetic preparation method therefor and use thereof | 🖼🧊📄§ | 2026-02-24 | 2040-03-05 | 0 | 31 |
| 12559575 | Isoform-independent antibodies to lipoprotein(a) | 🖼🧊📄§ | 2026-02-24 | 2041-04-27 | 0 | 31 |
| 12558388 | Use of radix actinidiae chinensis and extract thereof in preparation of medicine for treating ulcerative colitis | 🖼🧊📄§ | 2026-02-24 | 2044-01-12 | 0 | 31 |
| 12558345 | CHK1/2 inhibitors for use in the treatment of neuroblastomas and/or soft tissue sarcomas | 🖼🧊📄§ | 2026-02-24 | 2041-08-15 | 0 | 31 |
| 12558577 | Anti-human Trop-2 antibody and application thereof | 🖼🧊📄§ | 2026-02-24 | 2040-10-12 | 0 | 31 |
| 12559471 | 1,5-dihydro-2,4-benzodiazepine-3-one derivative and application thereof | 🖼🧊📄§ | 2026-02-24 | 2042-10-20 | 0 | 31 |
| 12559725 | Formulation comprising extracellular vesicles, method for producing the same, and uses thereof | 🖼🧊📄§ | 2026-02-24 | 2039-12-04 | 0 | 31 |
| 12558357 | Tetrahydroquinazoline derivatives as selective cytotoxic agents | 🖼🧊📄§ | 2026-02-24 | 2041-08-25 | 0 | 31 |
| 12558396 | Use of cyclo(His-Pro) (CHP) for preventing, alleviating or treating peritoneal fibrosis | 🖼🧊📄§ | 2026-02-24 | 2040-03-30 | 0 | 31 |
| 12558375 | Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy | 🖼🧊📄§ | 2026-02-24 | 2042-08-03 | 0 | 31 |
| 12558417 | Hepatitis A virus preparation method and hepatitis A virus prepared according to method | 🖼🧊📄§ | 2026-02-24 | 2040-12-18 | 0 | 31 |
| 12559470 | FGFR inhibitors and uses thereof | 🖼🧊📄§ | 2026-02-24 | 2039-09-12 | 0 | 31 |
| 12559525 | Conjugated fibronectin-binding peptides for use in tumor or fibrosis diagnosis and therapy | 🖼🧊📄§ | 2026-02-24 | 2042-10-05 | 0 | 31 |
| 12558365 | Methods of treating acute coronary syndromes | 🖼🧊📄§ | 2026-02-24 | 2040-03-12 | 0 | 31 |
| 12558399 | Isocyclosporin A for topical treatment of ocular diseases | 🖼🧊📄§ | 2026-02-24 | 2042-12-22 | 0 | 31 |
| 12559718 | Diagnostic methods for t cell therapy | 🖼🧊📄§ | 2026-02-24 | 2043-08-24 | 0 | 31 |
| 12558389 | Plant-based extract complex composition having the properties for supporting the relief of musculoskeletal pain, antibacterial and anti-inflammatory and process of manufacturing the same | 🖼🧊📄§ | 2026-02-24 | 2045-07-21 | 0 | 31 |
| 12558333 | Agent for ameliorating and/or preventing sickle cell disease | 🖼🧊📄§ | 2026-02-24 | 2040-09-18 | 0 | 31 |
| 12559553 | IL-31 modulators for treating FXR-induced pruritus | 🖼🧊📄§ | 2026-02-24 | 2042-06-17 | 0 | 31 |
| 12559527 | Compositions comprising V2 opt HIV envelopes | 🖼🧊📄§ | 2026-02-24 | 2040-10-23 | 0 | 31 |
| 12559485 | CDK6/DYRK2 dual-target inhibitor, and preparation method therefor and use thereof | 🖼🧊📄§ | 2026-02-24 | 2041-03-19 | 0 | 31 |
| 12558374 | Botanical film-forming acne compositions | 🖼🧊📄§ | 2026-02-24 | 2043-10-12 | 0 | 31 |
| 12560596 | Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy | 🖼🧊📄§ | 2026-02-24 | 2045-09-30 | 0 | 31 |
| 12559532 | Embryonic angiogenesis markers and diagnostic and therapeutic strategies based thereon | 🖼🧊📄§ | 2026-02-24 | 2044-06-20 | 0 | 31 |
| 12559474 | Triazine derivatives having virus replication inhibitory activity and pharmaceutical composition comprising the same | 🖼🧊📄§ | 2026-02-24 | 2042-02-17 | 0 | 31 |
| 12559769 | Methods and compositions for the activation of tumor cytotoxicity via human gamma-delta t-cells | 🖼🧊📄§ | 2026-02-24 | 2038-06-15 | 0 | 31 |
| 12558343 | Medical use of icaritin | 🖼🧊📄§ | 2026-02-24 | 2041-03-09 | 0 | 31 |
| 12558330 | Methods and compositions for treating edema refractory to oral diuretics | 🖼🧊📄§ | 2026-02-24 | 2045-05-14 | 0 | 31 |
| 12558440 | Radiopharmaceutical and methods | 🖼🧊📄§ | 2026-02-24 | 2043-04-17 | 0 | 31 |
| 12559749 | Methods of rescuing stop codons via genetic reassignment with ACE-tRNA | 🖼🧊📄§ | 2026-02-24 | 2043-04-21 | 0 | 31 |
| 12559569 | Methods of treating bleeding disorders by administration of chimeras comprising anti-von Willebrand factor antibodies and clotting factors | 🖼🧊📄§ | 2026-02-24 | 2042-12-20 | 0 | 31 |
| 12558340 | ANAVEX2-73 for the treatment of genetic neurodevelopmental disorders | 🖼🧊📄§ | 2026-02-24 | 2042-01-21 | 0 | 31 |
| 12559789 | Method of targeting patient-specific oncogenes in extrachromosomal DNA to treat glioblastoma | 🖼🧊📄§ | 2026-02-24 | 2038-01-19 | 0 | 31 |
| 12558325 | Methods for improving neurological diseases and disorders | 🖼🧊📄§ | 2026-02-24 | 2043-02-09 | 0 | 31 |
| 12559733 | Optimization of type IV BRAF inhibitors for the treatment of melanoma | 🖼🧊📄§ | 2026-02-24 | 2041-08-23 | 0 | 31 |
| 12558373 | Method for converting atrial fibrillation to sinus rhythm with low-risk, low-cost protocol, and preventing recurrence of atrial fibrillation | 🖼🧊📄§ | 2026-02-24 | 2044-10-04 | 0 | 31 |
| 12558392 | Herbal oral compositions having the properties for supporting and enhancing musculoskeletal health and method of manufacturing the same | 🖼🧊📄§ | 2026-02-24 | 2045-07-23 | 0 | 31 |
| 12558387 | Multi-virus anti-infectivity and pro-immunity assembly | 🖼🧊📄§ | 2026-02-24 | 2042-06-07 | 0 | 31 |
| 12558327 | Methods and compositions for treating sleep apnea | 🖼🧊📄§ | 2026-02-24 | 2040-02-07 | 0 | 31 |
| 12559545 | Human hendra virus and nipah virus antibodies and methods of use therefor | 🖼🧊📄§ | 2026-02-24 | 2040-11-12 | 0 | 31 |
| 12559487 | Crosslinked optically active secondary amine derivative | 🖼🧊📄§ | 2026-02-24 | 2040-09-25 | 0 | 31 |
| 12559539 | TGF-beta receptor fusion protein pharmaceutical composition and use thereof | 🖼🧊📄§ | 2026-02-24 | 2039-11-08 | 0 | 31 |
| 12558385 | Lactobacillus plantarum compositions and uses thereof | 🖼🧊📄§ | 2026-02-24 | 2039-06-13 | 0 | 31 |
| 12558350 | Compositions and methods for treatment | 🖼🧊📄§ | 2026-02-24 | 2042-07-27 | 0 | 31 |
| 12558424 | T cells having enhanced anti-tumor activity | 🖼🧊📄§ | 2026-02-24 | 2040-08-06 | 0 | 31 |
| 12558342 | 2-[2-({12,12-dimethyl-4-oxo-6-phenyl-3,11-dioxatricyclo[8.4.0.0,2,7]tetradeca-1,5,7,9-tetraen-8-yl}oxy)acetamido]benzamide and derivatives as inhibitor of clock:bmal1 interaction for the treatment of circadian rhythm diseases and disorders | 🖼🧊📄§ | 2026-02-24 | 2039-12-16 | 0 | 31 |